26.09.2019

Successful ESCRS in Paris

For numerous interested visitors and exhibitors, the 37th ESCRS Congress in Paris ended on the 18th of September 2019. HumanOptics AG can also look back on a successful exhibition. The focus of this year’s booth was set on the ASPIRA-aXA posterior chamber lens with XL optic and the unique CUSTOMFLEX® ARTIFICIALIRIS iris implant. The brisk […]
11.09.2019

Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR Erlangen, August 30, 2019 – The Management Board of HumanOptics AG (“Company”), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, (“Medipart”) that Medipart signed a share purchase agreement to sell its stake of 73.4% in the […]

    *Mandatory field

    HumanOptics expands production site in Germany

    News
    News

    In the final phase of last year, several important major investments were approved in line with HumanOptics Holding AG’s growth strategy. These will be implemented in the course of 2024 and will significantly increase production capacity by fully committing to the Germany location. The implementation of these measures has already begun, so that a significant […]